BioSig Technologies Inc. (BSGM)
BioSig Statistics
Share Statistics
BioSig has 23.04M shares outstanding. The number of shares has increased by 84.63% in one year.
| Shares Outstanding | 23.04M |
| Shares Change (YoY) | 84.63% |
| Shares Change (QoQ) | 5.88% |
| Owned by Institutions (%) | 2.31% |
| Shares Floating | 17.91M |
| Failed to Deliver (FTD) Shares | 77 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 183.44K, so 1.06% of the outstanding shares have been sold short.
| Short Interest | 183.44K |
| Short % of Shares Out | 1.06% |
| Short % of Float | 1.37% |
| Short Ratio (days to cover) | 0.56 |
Valuation Ratios
The PE ratio is -1.2 and the forward PE ratio is -1.26. BioSig's PEG ratio is 0.03.
| PE Ratio | -1.2 |
| Forward PE | -1.26 |
| PS Ratio | 1940.06 |
| Forward PS | 0.2 |
| PB Ratio | -11.99 |
| P/FCF Ratio | -2 |
| PEG Ratio | 0.03 |
Enterprise Valuation
BioSig Technologies Inc. has an Enterprise Value (EV) of 35.18M.
| EV / Earnings | -1.21 |
| EV / Sales | 1954.61 |
| EV / EBITDA | -1.25 |
| EV / EBIT | -1.23 |
| EV / FCF | -2.01 |
Financial Position
The company has a current ratio of 0.12, with a Debt / Equity ratio of -0.16.
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | -0.16 |
| Total Debt / Capitalization | -18.37 |
| Cash Flow / Debt | -38.3 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 9.97% and return on capital (ROIC) is 1170.92%.
| Return on Equity (ROE) | 9.97% |
| Return on Assets (ROA) | -16.15% |
| Return on Capital (ROIC) | 1170.92% |
| Revenue Per Employee | $4,500 |
| Profits Per Employee | $-7,260,250 |
| Employee Count | 4 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -6.2% in the last 52 weeks. The beta is 0.43, so BioSig's price volatility has been higher than the market average.
| Beta | 0.43 |
| 52-Week Price Change | -6.2% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 0.83 |
| Relative Strength Index (RSI) | 41.07 |
| Average Volume (20 Days) | 295.77K |
Income Statement
In the last 12 months, BioSig had revenue of 18K and earned -29.04M in profits. Earnings per share was -3.95.
| Revenue | 18K |
| Gross Profit | 18K |
| Operating Income | -28.51M |
| Net Income | -29.04M |
| EBITDA | -28.15M |
| EBIT | -28.51M |
| Earnings Per Share (EPS) | -3.95 |
Balance Sheet
The company has 190K in cash and 452K in debt, giving a net cash position of -262K.
| Cash & Cash Equivalents | 190K |
| Total Debt | 452K |
| Net Cash | -262K |
| Retained Earnings | -245.01M |
| Total Assets | 1.42M |
| Working Capital | -853K |
Cash Flow
In the last 12 months, operating cash flow was -17.31M and capital expenditures -186K, giving a free cash flow of -17.5M.
| Operating Cash Flow | -17.31M |
| Capital Expenditures | -186K |
| Free Cash Flow | -17.5M |
| FCF Per Share | -2.38 |
Margins
Gross margin is 100%, with operating and profit margins of -158.4K% and -161.34K%.
| Gross Margin | 100% |
| Operating Margin | -158.4K% |
| Pretax Margin | -159.39K% |
| Profit Margin | -161.34K% |
| EBITDA Margin | -156.39K% |
| EBIT Margin | -158.4K% |
| FCF Margin | -97.22K% |
Dividends & Yields
BSGM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -637.1% |
| FCF Yield | -122.97% |
Analyst Forecast
The average price target for BSGM is $2.75, which is 343.5% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.75 |
| Price Target Difference | 343.5% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 2, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Feb 2, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -285.95 |
| Piotroski F-Score | 4 |